Birth defects research. Part A, Clinical and molecular teratology
-
Birth Defects Res. Part A Clin. Mol. Teratol. · Apr 2007
Maternal use of selective serotonin re-uptake inhibitors in early pregnancy and infant congenital malformations.
Maternal use of selective serotonin re-uptake inhibitors (SSRIs) has recently been associated with an increased risk for certain malformations. ⋯ Use of SSRIs in early pregnancy does not seem to be a major risk factor for infant malformations. The association between paroxetine use and infant cardiovascular defects may be a result of multiple testing, but is supported by other studies.